Magdalena Budisteanu

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Magdalena Budisteanu.png

Magdalena Budisteanu, M.D., PhD., is a medical doctor and researcher specializing in pediatric neurology at "Prof. Dr. Alexandru Obregia” Clinical Hospital of Psychiatry, Bucharest, Romania.[1] Her particular research interests include genetic disorders and autism spectrum disorder.

Education[edit | edit source]

  • 1995, Doctor of Medicine, Faculty Medicine Craiova. Doctor of Philosophy, Faculty Medicine Craiova, Romania
  • 2001, PhD in Pediatrics Neurology, Carol Davila University Medicine Bucharest, Romania

EUROMENE[edit | edit source]

Dr. Budisteanu is a member of the Clinical Research Enablers and Diagnostic Criteria Working Group on behalf of EUROMENE, a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[2]

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

  • PubMed
  • Twitter
  • Facebook
  • Website

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. "Magdalena Budisteanu Curriculum Vitae" (PDF). Victor Babes” National Institute of Pathology (INCDVB). February 4, 2019.
  2. "Action CA15111". COST. Retrieved February 4, 2019.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.